The research

The programs that we cofinance

Since the creation of the association in 2011, we have allocated MORE THAN 20 MILLION EUROS to 61 French and European research programs to accelerate research against childhood cancer.

Our strategy consists of funding fundamental and translational research programs to better understand the causes of childhood cancer and resistance to treatments, as well as early phase clinical trials that allow children who suffer relapse or therapeutic failure to benefit from innovative personalized treatments, thanks to precision medicine.

Since 2012, the programs that we have co-funded have come from recommendations from experts in pediatric oncology: the European consortium ITCC *, the SFCE ** and, since 2020, the scientific committee of Fight Kids Cancer.

* Innovative Therapies for Children with Cancer
** Société Française de lutte contre les Cancers et leucémies de l’Enfant et de l’adolescent

BETTER UNDERSTAND

It means finding the “weakness” of the tumor in order to target the best possible treatment, by analyzing the complete sequencing of tumors or leukemia. It also consists in analyzing all the available data in order to better understand childhood cancer.

BETTER CURE

It means proposing better adapted, better targeted and therefore more effective therapies. Some of the programs that we finance offer treatments that are particularly innovative, such as immunotherapy.

SACHA : le programme qui sécurise l’accès aux médicaments en dehors des essais cliniques

Context of the SACHA Study France stands as a pioneer in Europe in the field of developing new drugs in pediatric oncology. For example, from 2015 to 2018, over 2,200…

FIGHT KIDS CANCER 2024 LAUNCHES A CALL FOR EUROPEAN PROJECTS DEDICATED TO BRAIN TUMORS

On the occasion of September in GOLD, Fight Kids Cancer, an initiative created by Imagine for Margo and its European partners, is launching a new call for projects to boost…

SACHA: Accelerate children’s access to innovative molecules – Interview with Dr. Pablo Berlanga

France is a pioneer in Europe in the development of new drugs in pediatric oncology. For example, within the ITCC network (Innovative Therapies for Children and adolescents with Cancer, 14…

Conventions and conferences

Conventions and conferences

Conventions and conferences

Understand, analyze, testify, exchange, propose, enlist: being on all the fronts to defend our cause and accelerate the decision process and the action in favor of research. Since the creation of the association, we participate in the main conventions and conferences on pediatric cancers in France and internationally.

Enlist the research stakeholders

Enlist the research stakeholders

Enlist the research stakeholders

Beyond the financial assistance that we bring to the researchers, we enlist and unite the research stakeholders in France and Europe so that childhood cancer becomes a priority for all.
Every year in February, we organize a seminar to bring together the research players in France.
FEB
11

10th edition seminar FAST

11 February 2023

Our scientific partners

ITCC
SFCE
Gustave Roussy
Institut Curie

Words that move us

“The Imagine for Margo association has helped place childhood cancer on the European agenda. Thanks to Imagine for Margo, we are gaining time and we are implementing tests that would not have started for lack of funding.”

Professor Gilles VASSAL, Director of Research at Gustave Roussy

“I would like to thank you for bringing us together again and again for this cause and to remind us what we are striving for. Because at the end, it's the patients that we want to help and in this sense your support is very helpful."

Dr. Stefan Pfister, Chair of the Biology Committee at ITCC

“Imagine for Margo provides huge support in backing our projects financially, in a significant and constant manner. This allows us to move forward faster in our research”

Birgit Geoerger, researcher at Gustave Roussy, director of the MAPPYACTS and ESMART programs

“The work that the association does to bring together, at the same time, researchers, clinicians, laboratories, pharmaceuticals, the families, is really something extremely important. The financial help is of course very important, but what Imagine for Margo brings goes beyond that.”

Gudrun Schleiermacher, researcher at the Curie Institute, director of the MICCHADO program